In prostate cancer cells, Mdm2 competes with E3 ubiquitin ligase SCFSkp2 to bind to E2F1 and inhibits the ubiquitination of E2F1, thereby up-regulating the protein level of E2F1 [106]. The gene discussed is E2F1; the disease is prostate carcinoma.